Jack Alistair Sargeant

14PUBLICATIONS
28CO-AUTHORS
Medical biochemistry - lipidsPharmacogenomicsFood properties (incl. characteristics and health benefits)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 09, 2024
Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction-associated steatotic liver disease but is not altered by 6 weeks of exercise training.

Scott A Willis, Sundus Malaikah, Stephen J Bawden

|Aug 19, 2023
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.

Jonathan Goldney, Jack A Sargeant, Melanie J Davies

|Apr 20, 2022
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial.

Jack A Sargeant, James A King, Thomas Yates

|Sep 21, 2021
The role of hepatic lipid composition in obesity-related metabolic disease.

Scott A Willis, Stephen J Bawden, Sundus Malaikah

|Feb 10, 2021
Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.

Ehtasham Ahmad, Helen L Waller, Jack A Sargeant

|Dec 02, 2020
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?

Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi

Pageof 3

Frequent Collaborators

8 joint publications

Melanie Jane Davies

6 joint publications

Kamlesh Khunti

6 joint publications

James A King

5 joint publications

Kamlesh Khunti